AFFX draws a line in the chip

Corporate collegiality hasn't prevented Affymetrix Inc. from suing Synteni Inc., a gene expression microarray (GEM) company, and Incyte Pharmaceuticals Inc., which is acquiring Synteni.

AFFX and INCY have a joint venture under a 1996 agreement to commercialize five AFFX arrays in the expression monitoring field.

Read the full 440 word article

User Sign In